Efficacy and safety of recombinant human activated protein C for severe sepsis. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) N Engl J Med 344: 699-709 Platelet aggregation by fibrinogen polymers crosslinked across the E domain. McManama G, Lindon JN, Kloczewiak M, Smith MA, Ware JA, Hawiger J, Merrill EW, Salzman EW (1986) Blood 68: 363-71 Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial. Balaguer JM, Yu C, Byrne JG, Ball SK, Petracek MR, Brown NJ, Pretorius M (2013) Clin Pharmacol Ther 93: 326-34 Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Bernard GR, Ely EW, Wright TJ, Fraiz J, Stasek JE, Russell JA, Mayers I, Rosenfeld BA, Morris PE, Yan SB, Helterbrand JD (2001) Crit Care Med 29: 2051-9 Missing covariate data in medical research: to impute is better than to ignore. Janssen KJ, Donders AR, Harrell FE, Vergouwe Y, Chen Q, Grobbee DE, Moons KG (2010) J Clin Epidemiol 63: 721-7 Monitoring activity of fibrinolytic agents. A therapeutic challenge. Shafer KE, Santoro SA, Sobel BE, Jaffe AS (1984) Am J Med 76: 879-86 Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen. Hogg PJ, Jackson CM, Labanowski JK, Bock PE (1996) J Biol Chem 271: 26088-95 Complex formation of platelet membrane glycoproteins IIb and IIIa with the fibrinogen D domain. Nachman RL, Leung LL, Kloczewiak M, Hawiger J (1984) J Biol Chem 259: 8584-8 Interaction of fibrinogen with staphylococcal clumping factor and with platelets. Hawiger J, Kloczewiak M, Timmons S, Strong D, Doolittle RF (1983) Ann N Y Acad Sci 408: 521-35 Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community. Joseph J, Pencina MJ, Wang TJ, Hayes L, Tofler GH, Jacques P, Selhub J, Levy D, D'Agostino RB, Benjamin EJ, Vasan RS (2009) J Hypertens 27: 1317-24 Reactivity of chemically cross-linked fibrinogen and its fragments D toward the staphylococcal clumping receptor. Kloczewiak M, Timmons S, Hawiger J (1987) Biochemistry 26: 6152-6 Elevated D-dimer is independently associated with endothelial dysfunction: a cross-sectional study in HIV-infected adults on antiretroviral therapy. Hileman CO, Longenecker CT, Carman TL, Milne GL, Labbato DE, Storer NJ, White CA, McComsey GA (2012) Antivir Ther 17: 1345-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.